M. Noguchi et al.
Bull. Chem. Soc. Jpn., 74, No. 5 (2001) 923
xazolo[4,3-c]pyridine (4b) was known.4
(8-C), 61.7, 61.8 (3a-C and 5-C), 74.4 (2-C), 158.0 (5′-C); FAB
MS m/z (rel intensity) 469 (Mꢃ ꢃ H; base peak), 468 (44), 389
(26). Found: C, 45.90; H, 7.70; N, 11.83%. Calcd for
C18H36N4O6S2: C, 46.13; H, 7.74; N, 11.96%.
Thermal Reaction of Oximes 10 and 13. A similar reaction
and work-up for oximes 10 and 13 gave NH-nitrone cycloadducts
14 and 15, respectively; the results are summarized in Table 2. 5-
Benzyl-7,7-dimethyl-3-phenylperhydroisoxazolo[4,3-c]pyridine
(14a) is known.4
3,6,6-Trimethyl-1-tosyl-2,3,6,7-tetrahydro-1H-1,4-diazepine
4-Oxide (6b). Pale yellow oil. This compound was not very sta-
ble, and the structure was determined based on the spectroscopic
data given below: 1H NMR (270 MHz) δ 1.23, 1.43 (each s, each 3
H, 6-Me2), 1.63 (d, J ꢀ 6.9 Hz, 3 H, 3-Me), 2.82 (s, 3 H, Me),
2.92 (d, J ꢀ 13.2 Hz, 1 H, 7-H), 3.26–3.33 (ov, 2 H, 2-H and 7-H),
3.50 (dd, J ꢀ 5.6 and 14.5 Hz, 1 H, 2-H), 4.50 (m, 1 H, 3-H), 7.00
(s, 1 H, 5-H) , 7.34, 7.64 (each br d, J ꢀ 8.3 Hz, each 2 H, Ar-H).
2-[N-(3-Hydroxyimino-2,2-dimethylpropyl)-N-tosylamino-
methyl]-4,4,8-trimethyl-6-tosyl-perhydroisoxazolo[2,3-d]-
[1,4]diazepine (7b). Colorless needles from hexane–benzene;
mp 174–175 ˚C; IR (KBr) 3300, 1320, 1140 cmꢁ1; 1H NMR (270
MHz) δ 0.67, 0.97 (each s, each 3 H, 4-Me2), 1.11, 1.13 (each s,
each 3 H, 4′-Me2), 1.17 (d, J ꢀ 6.3 Hz, 3 H, 8-Me), 1.65 (br q, J ꢀ
11.5 Hz, 1 H, 3-H), 1.86 (m, 1 H, 3-H), 2.35 (d, J ꢀ 13.9 Hz, 1 H,
5-H), 2.38, 2.41 (each s, each 3 H, Meꢂ2), 2.74 (dd, J ꢀ 4.0 and
13.2 Hz, 1 H, 7-H), 3.12–3.21 (ov, 2 H, 1′-H and 3a-H), 3.28 (d, J
ꢀ 13.9 Hz, 1 H, 5-H), 3.40–3.62 (ov, 5 H, 7-H2, 8-H, and 3′-H2),
3.65 (d, J ꢀ 14.5 Hz, 1 H, 1′-H), 7.26–7.31 (ov, 4 H, Ar-H), 7.40
(s, 1 H, 5′-H), 7.61, 7.67 (each br d, J ꢀ 8.3 Hz, each 2 H, Ar-H),
8.11 (s, 1 H, OH); 13C NMR (67.8 MHz) δ 9.65 (8-Me), 19.8, 26.2
(4-Me2), 21.4, 21.5 (Meꢂ2), 23.2, 24.4 (4′-Me2), 36.2 (3-C), 36.3
(4-C), 38.6 (4′-C), 50.1 (2-C), 55.5 (7-C), 55.6 (3-C), 56.7 (8-C),
61.1 (3a-C), 61.8 (6-C), 74.9 (2-C), 127.0, 127.2, 129.7, 135.7,
137.4, 143.4 (Ph-C), 157.8 (5′-C); FAB MS m/z (rel intensity) 621
(Mꢃ ꢃ H; base peak), 620 (48), 532 (8), 465 (26). Found: C,
57.82; H, 7.28; N, 9.02%. Calcd for C30H44N4O6S2: C, 58.04; H,
7.14; N, 9.03%.
7,7-Dimethyl-5-tosyl-3-phenylperhydroisoxazolo[4,3-c]pyri-
dine (14b). Colorless needles from EtOH; mp 187–188 ˚C; IR
1
(KBr) 3220, 1330, 1155 cmꢁ1; H NMR (270 MHz) δ 0.97, 1.12
(each s, each 3 H, 7-Me2), 2.45 (s, 3 H, SO2Me), 2.45–2.57 (ov, 2
H, 4-H and 6-H), 2.83 (m, 1 H, 3a-H), 3.13–3.17 (ov, 2 H, 6-H and
7a-H), 3.80 (br s, 1 H, 3a-H), 5.94 (br, 1 H, NH), 7.26–7.39 (ov, 7
H, Ar-H), 7.66 (br d, J ꢀ 8.3 Hz, 2 H, Ar-H); 13C NMR (67.8
MHz) δ 21.5 (Me), 24.6, 26.7 (7-Me2), 32.6 (7-C), 45.6 (4-C),
47.5 (3a-C), 52.4 (6-C), 63.1 (7a-C), 83.6 (3-C), 125.0, 127.5,
127.7, 128.6, 129.8, 133.3, 140.8, 143.8 (Ph-C). Found: C, 65.08;
H, 7.00; N, 7.30%. Calcd for C21H26N2O3S: C, 65.26; H, 6.78; N,
7.25%.
5-Acetyl-7,7-dimethyl-3-phenylperhydroisoxazolo[4,3-c]pyr-
idine (14c). Colorless oil; IR (NaCl) 3200, 1630 cmꢁ1
. This
1
compound was a (4:1) mixture of two atropisomers in CDCl3. H
NMR (270 MHz) major isomer δ 1.00, 1.04 (each s, each 3 H, 7-
Me2), 2.11 (s, 3 H, COMe), 2.68 (m, 1 H, 3a-H), 3.03 (br t, J ꢀ
13.0 Hz, 1 H, 4-H), 3.18–3.32 (ov, 4 H, 6-H2, 7a-H, and NH), 4.61
(dd, J ꢀ 6.3 and 13.2 Hz, 1 H, 4-H), 4.85 (d, J ꢀ 2.0 Hz, 1 H, 3-
H), 7.28–7.41 (ov, 5 H, Ph); minor isomer (assigned signals) δ
0.97, 1.02 (each s, 7-Me2), 2.18 (s, COMe), 2.82 (d, J ꢀ 13.2 Hz,
6-H), 3.35 (dd, J ꢀ 11.2 and 13.9 Hz, 4-H), 3.88 (ddd, J ꢀ 1.6,
6.6, and 13.9 Hz, 4-H), 4.03 (d, J ꢀ 13.2 Hz, 6-H), 4.81 (d, J ꢀ
1.7 Hz, 3-H); 13C NMR (67.8 MHz) δ 21.3, 21.4 (COMe), 24.2,
24.3, 26.3 (7-Me2), 32.6, 33.3 (7-C), 40.7, 45.8 (4-C), 47.1, 47.7
(3a-C), 47.9, 52.9 (6-C), 64.0, 64.7 (7a-C), 83.9, 84.1 (3-C),
125.3, 127.9, 128.7, 140.7 (Ph-C), 168.9 (COMe). Found: C,
70.00; H, 8.31; N, 10.01%. Calcd for C16H22N2O2: C, 70.04; H,
8.08; N, 10.21%.
5-Mesyl-7,7-dimethylperhydroisoxazolo[4,3-c]pyridine (4c).
Colorless prisms from hexane–benzene; mp 168–169 ˚C; IR
1
(KBr) 3200, 1320, 1160 cmꢁ1; H NMR (270 MHz) δ 1.00, 1.19
(each s, each 3 H, 7-Me2), 2.73–2.78 (ov, 2 H, 4-H and 6-H), 2.78
(s, 3 H, SO2Me), 2.88 (m, 1 H, 3a-H), 3.19 (d, J ꢀ 12.2 Hz, 1 H,
6-H), 3.26 (br s, 1 H, 7a-H), 3.71 (d, J ꢀ 7.9 Hz, 1 H, 3-H), 3.74
(m, 1 H, 4-H), 3.94 (dd, J ꢀ 4.6 and 7.9 Hz, 1 H, 3-H), 5.89 (br s,
1 H, NH); 13C NMR (67.8 MHz) δ 24.6, 26.2 (7-Me2), 32.6 (7-C),
34.5 (SO2Me), 40.0 (3a-C), 44.6 (4-C), 51.3 (6-C), 64.8 (7a-C),
71.8 (3-C). Found: C, 45.96; H, 7.74; N, 11.91%. Calcd for
C9H18N2O3S: C, 46.13; H, 7.74; N, 11.96%.
5-Benzyl-7,7-dimethylperhydroisoxazolo[4,3-c]pyridin-4-
one (15a). Colorless prisms from hexane–benzene; mp 90–91
1
1-Mesyl-3,6,6-trimethyl-2,3,6,7-tetrahydro-1H-1,4-diaze-
pine 4-Oxide (6c). Pale-yellow oil. This compound was not
very stable, and the structure was determined based on the spec-
˚C; IR (KBr) 3200, 1630 cmꢁ1; H NMR (270 MHz) δ 0.85 (s, 6
H, 7-Me2), 2.66 (dd, J ꢀ 1.3 and 12.5 Hz, 1 H, 6-H), 3.23 (d, J ꢀ
12.5 Hz, 1 H, 6-H), 3.27–3.37 (ov, 4 H, 3a-H, 6-H, 7a-H, and NH),
3.94 (br t, J ꢀ 7.8 Hz, 1 H, 3-H), 4.48 (br d, J ꢀ 7.8 Hz, 1 H, 3-
H), 4.41, 4.61 (each d, J ꢀ 14.5 Hz, each 1 H, CH2Ph), 7.17–7.28
(ov, 5 H, Ph); 13C NMR (67.8 MHz) δ 23.3, 25.2 (7-Me2), 33.0 (7-
C), 48.9 (3a-C), 50.8 (CH2Ph), 53.9 (6-C), 66.5 (7a-C), 77.6 (3-
C), 127.6, 128.4, 128.6, 136.5 (Ph-C), 169.9 (4-CO). Found: C,
69.29; H, 8.00; N, 10.61%. Calcd for C15H20N2O2: C, 69.20; H,
7.74; N, 10.76%.
5-Benzyl-3,7,7-trimethylperhydroisoxazolo[4,3-c]pyridin-4-
one (15b). Colorless prisms from hexane–benzene; mp 79–80
˚C; IR (KBr) 3170, 1620 cmꢁ1; 1H NMR (270 MHz) δ 0.91 (br s,
6 H, 7-Me2), 1.44 (d, J ꢀ 6.3 Hz, 3 H, 3-Me), 2.73 (d, J ꢀ 12.9
Hz, 1 H, 6-H), 2.90 (dd, J ꢀ 5.3 and 8.6 Hz, 1 H, 3a-H), 3.30 (d, J
ꢀ 12.9 Hz, 1 H, 6-H), 3.37 (d, J ꢀ 8.6 Hz, 1 H, 7a-H), 4.17 (br, 1
H, 3a-H), 4.49, 4.65 (each d, J ꢀ 14.5 Hz, each 1 H, CH2Ph), 5.4–
5.8 (br, 1 H, NH), 7.24–7.36 (ov, 5 H, Ph); 13C NMR (67.8 MHz)
δ 19.3 (3-Me), 23.0, 25.3 (7-Me2), 32.2 (7-C), 50.5 (CH2Ph), 53.6
(6-C), 54.4 (3a-C), 66.5 (7a-C), 82.6 (3-C), 127.5, 128.3, 128.5,
136.5 (Ph-C), 169.3 (4-CO). Found: C, 69.89; H, 8.41; N,
10.11%. Calcd for C16H22N2O2: C, 70.04; H, 8.08; N, 10.21%.
1
troscopic data given below: H NMR (270 MHz) δ 1.27, 1.33
(each s, each 3 H, 6-Me2), 1.63 (d, J ꢀ 7.3 Hz, 3 H, 3-Me), 2.85
(s, 3 H, SO2Me), 3.17, 3.39 (each d, J ꢀ 13.2 Hz, each 1 H, 7-H2),
3.35–3.55 (ov, 2 H, 2-H2), 4.40 (m, 1 H, 3-H), 7.03 (s, 1 H, 5-H).
2-[N-(3-Hydroxyimino-2,2-dimethylpropyl)-N-mesylami-
nomethyl]-4,4,8-trimethyl-6-mesylperhydroisoxazolo[2,3-d]-
[1,4]diazepine (7c). Colorless prisms from ethyl acetate; mp
188 ˚C; IR (KBr) 3400, 1330, 1170 cmꢁ1; 1H NMR (270 MHz) δ
0.95, 0.99 (each s, each 3 H, 4-Me2), 1.14, 1.16 (each s, each 3 H,
4′-Me2), 1.23 (d, J ꢀ 3.0 Hz, 3 H, 8-Me), 1.75 (ddd, J ꢀ 10.9,
11.2, and 12.5 Hz, 1 H, 3-H), 2.10 (ddd, J ꢀ 2.0, 5.6, and 12.5 Hz,
1 H, 3-H), 2.69 (d, J ꢀ 13.9 Hz, 1 H, 5-H), 2.78, 2.92 (each s,
each 3 H, SO2Meꢂ2), 3.10 (dd, J ꢀ 4.0 and 12.9 Hz, 1 H, 7-H),
3.29 (dd, J ꢀ 3.3 and 11.2 Hz, 1 H, 3a-H), 3.32–3.43 (ov, 2 H, 1′-
H and 5-H), 3.42 (s, 2 H, 3′-H2), 3.52–3.58 (ov, 2 H, 7-H and 1′-
H), 3.69 (m, 1 H, 8-H), 4.13 (m, 1 H, 2-H), 7.20 (s, 1 H, 5′-H),
7.41 (s, 1 H, OH); 13C NMR (67.8 MHz) δ 9.76 (8-Me), 20.2, 26.2
(4-Me2), 23.0, 24.3 (4′-Me2), 35.7, 39.7 (SO2Meꢂ2), 36.0 (3-C),
36.6 (4-C), 38.6 (4′-C), 50.2 (1′-C), 54.9 (3′-C), 55.3 (7-C), 55.9